BioRestorative Accounts Payable from 2010 to 2025

BRTX Stock  USD 1.94  0.12  6.59%   
BioRestorative Therapies Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 161.9 K in 2025. Accounts Payable is the amount BioRestorative Therapies owes to suppliers or vendors for products or services received but not yet paid for. It represents BioRestorative Therapies' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2009-12-31
Previous Quarter
215.9 K
Current Value
401.4 K
Quarterly Volatility
884.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.7 M or Depreciation And Amortization of 178.1 K, as well as many indicators such as Price To Sales Ratio of 54.99, Dividend Yield of 0.0 or PTB Ratio of 0.69. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.
  
Check out the analysis of BioRestorative Therapies Correlation against competitors.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Latest BioRestorative Therapies' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of BioRestorative Therapies over the last few years. An accounting item on the balance sheet that represents BioRestorative Therapies obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of BioRestorative Therapies are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. BioRestorative Therapies' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

BioRestorative Accounts Payable Regression Statistics

Arithmetic Mean974,752
Geometric Mean445,246
Coefficient Of Variation98.07
Mean Deviation836,851
Median771,429
Standard Deviation955,973
Sample Variance913.9B
Range2.5M
R-Value(0.28)
Mean Square Error901B
R-Squared0.08
Significance0.29
Slope(56,747)
Total Sum of Squares13.7T

BioRestorative Accounts Payable History

2025161.9 K
2024170.4 K
2023189.4 K
2022170.9 K
202150.8 K
2020118.9 K
2019M

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable170.4 K161.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.